Volume 14, Issue 1 supplement

April 2019

Lp(a) – Update 2018

Issue Editors:

9 articles in this issue

Lipoprotein(a)
K. P. Mellwig
A. Vogt
Editorial Open access 03 April 2019 Pages: 1 - 4
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region
Florian Kronenberg
ReviewPaper Open access 11 March 2019 Pages: 5 - 12
Lipoprotein(a) and mortality—a high risk relationship
Reinhard Klingel
Andreas Heibges
Cordula Fassbender
OriginalPaper Open access 05 March 2019 Pages: 13 - 19
Lipoprotein(a)—an interdisciplinary challenge
U. Julius
S. Tselmin
S. R. Bornstein
OriginalPaper Open access 05 March 2019 Pages: 20 - 27
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?
Alexander Heinrich Nave
Arnold von Eckardstein
OriginalPaper Open access 05 March 2019 Pages: 28 - 32
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
V. J. J. Schettler
C. L. Neumann
Scientific Board of GLAR for the German Apheresis Working Group
OriginalPaper Open access 05 March 2019 Pages: 33 - 38
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Norbert Weiss
Ulrich Julius
OriginalPaper Open access 15 March 2019 Pages: 39 - 44
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U. Julius
S. Tselmin
S. R. Bornstein
OriginalPaper Open access 05 March 2019 Pages: 45 - 50
Lipoprotein(a)—antisense therapy
Anja Vogt
OriginalPaper Open access 11 March 2019 Pages: 51 - 56

Navigation